packageEnavogliflozin

enavogliflozin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Enavogliflozin is an SGLT2 inhibitor, a class of blood glucose lowering drugs, investigated for treating diabetes. It remains investigational and is not an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q123598885 and the WHO ATC classification; not checked by a person.

name:enavogliflozin
ATC codes:A10BK09
DrugBank:DB18970
PubChem CID:71076840
Wikidata:Q123598885
formula:C24H27ClO6
molar mass:446.924 g/mol (PubChem CID 71076840)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown